Cesca Therapeutics Inc. (KOOL) Q2 2019 Earnings Conference Call August 13, 2019 16:30 ET Company Participants Paula Schwartz - Managing Director, Rx Communications Chris Xu - Chairman & Chief Executive Officer Jeff Cauble - Principal Accounting Officer Conference Call Part...

Cesca Therapeutics (NASDAQ: KOOL ): Q2 GAAP EPS of -$0.47 beats by $0.13 . More news on: Cesca Therapeutics Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...

RANCHO CORDOVA, Calif. , Aug. 13, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, today announced improved financial and operating results for the second quarter e...